Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable ...

Chantar, principal investigator at CIC bioGUNE and CIBERehd, has identified a new therapeutic target for cholangiocarcinoma ...

A novel drug-releasing system for bladder cancer that allows for sustained delivery of medicine for several weeks recently received FDA approval after producing superior and longer-lasting response ...

The tumor microenvironment (TME) is a complex and dynamic ecosystem that plays a pivotal role in cancer progression and ...

Discover the latest on Arbutus Biopharma’s patent litigation strategy and investment risks. Learn if ABUS is a speculative ...

Intelligent diagnosis and treatment nanomaterials are at the cutting edge of biomedical research, leveraging advancements in nanotechnology to address ...

Today, the Blavatnik Awards for Young Scientists announced the Finalists for the 2025 Blavatnik National Awards. Three will ...

Discover why Fulgent’s accelerating revenue and rising margins signal growth potential, with shares undervalued vs. cash.

HIV globally, and that number continues to rise. While therapies exist to reduce the amount of HIV in a patient's body and, ...

Check out what is new and what is next in the natural proucts industry with the latest dietary supplements, branded ...